1. Home
  2. ALT vs SDA Comparison

ALT vs SDA Comparison

Compare ALT & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • SDA
  • Stock Information
  • Founded
  • ALT 1997
  • SDA 2007
  • Country
  • ALT United States
  • SDA China
  • Employees
  • ALT N/A
  • SDA N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • SDA Blank Checks
  • Sector
  • ALT Health Care
  • SDA Finance
  • Exchange
  • ALT Nasdaq
  • SDA Nasdaq
  • Market Cap
  • ALT 292.8M
  • SDA 263.8M
  • IPO Year
  • ALT N/A
  • SDA N/A
  • Fundamental
  • Price
  • ALT $3.61
  • SDA $2.24
  • Analyst Decision
  • ALT Strong Buy
  • SDA Buy
  • Analyst Count
  • ALT 6
  • SDA 1
  • Target Price
  • ALT $18.20
  • SDA $3.50
  • AVG Volume (30 Days)
  • ALT 3.5M
  • SDA 107.5K
  • Earning Date
  • ALT 08-15-2025
  • SDA 09-15-2025
  • Dividend Yield
  • ALT N/A
  • SDA N/A
  • EPS Growth
  • ALT N/A
  • SDA N/A
  • EPS
  • ALT N/A
  • SDA N/A
  • Revenue
  • ALT $20,000.00
  • SDA $458,905,000.00
  • Revenue This Year
  • ALT N/A
  • SDA $20.77
  • Revenue Next Year
  • ALT $346,228.97
  • SDA $19.32
  • P/E Ratio
  • ALT N/A
  • SDA N/A
  • Revenue Growth
  • ALT N/A
  • SDA 24.15
  • 52 Week Low
  • ALT $2.90
  • SDA $2.13
  • 52 Week High
  • ALT $11.16
  • SDA $11.74
  • Technical
  • Relative Strength Index (RSI)
  • ALT 34.75
  • SDA 35.85
  • Support Level
  • ALT $3.58
  • SDA $2.13
  • Resistance Level
  • ALT $4.39
  • SDA $2.45
  • Average True Range (ATR)
  • ALT 0.19
  • SDA 0.14
  • MACD
  • ALT -0.00
  • SDA -0.00
  • Stochastic Oscillator
  • ALT 4.65
  • SDA 33.33

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform.

Share on Social Networks: